Benjamin Shapiro - 31 Dec 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Benjamin Shapiro
Issuer symbol
ORMP
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 17:20:23 UTC
Previous filing
09 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shapiro Benjamin Director 1185 AVENUE OF THE AMERICAS, NEW YORK /s/ Benjamin Shapiro 05 Jan 2026 0001974846

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +30,000 +33% 119,720 31 Dec 2025 Direct F1
transaction ORMP Common Stock Award +3,500 +2.9% 123,220 31 Dec 2025 Direct F2
holding ORMP Common Stock 1,900,000 31 Dec 2025 By trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
F2 Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.
F3 These shares of Common Stock are held by a trust of which the reporting person is a trustee and beneficiary.